Obesity

Weight Management Weight Loss Treatment Options Weight Loss Treatments Health Risks Treatment Causes Medications Body Mass Index Childhood Obesity

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

Lowering cerebrospinal fluid pressure produced significant migraine relief without affecting weight in the initial trial.

Bioelectrical Impedance Analysis Outperforms BMI in Predicting Long-Term Mortality

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

New Wrist-Worn Algorithm Boosts Calorie Tracking Accuracy for People With Obesity

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

High BMI and Black Patients Face Greater Minor Complication Risks After Bariatric Surgery

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

Scientists Identify 'Meal Memory' Neurons That Regulate Hunger and Satiety

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Obesity Disrupts Olfactory Pathway That Reduces Hunger in Mice

Weight stigma reduction, not weight loss, key to post-bariatric mental health improvements

Switching to Low-Fat Diet Slows Precancerous Pancreatic Lesions in Obese Mice

US Teen Wegovy Prescriptions Jump 50% in 2024 and Reach 17.3 per 100,000 by March 2025

GLP-1 Drugs Associated with Reduced Obesity-Related Cancer and Mortality Risks

Abdominal Fat Identified as Major Independent Risk Factor for Psoriasis

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Cysteine Depletion in Mice Triggers 30% Weight Loss in One Week